DeepMed Research

University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors

Phase 2

Recruiting

Conditions: Glioma
IDH Mutation
Cholangiocarcinoma
Solid Tumor

Interventions: Drug: Olaparib
Drug: Durvalumab

First Posted Date: 2019-06-19

Last Posted Date: 2024-07-18

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 58

Registration Number: NCT03991832

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer

Phase 1

Recruiting

Conditions: Non-small Cell Carcinoma

Interventions: Drug: Binimetinib
Drug: Pembrolizumab

First Posted Date: 2019-06-19

Last Posted Date: 2024-07-16

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 40

Registration Number: NCT03991819

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada

Symptom Screening With Targeted Early Palliative Care (STEP) Versus Usual Care for Patients With Advanced Cancer

Not Applicable

Terminated

Conditions: Cancer

Interventions: Behavioral: Symptom screening with Targeted Early Palliative Care (STEP)

First Posted Date: 2019-06-17

Last Posted Date: 2022-05-23

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 69

Registration Number: NCT03987906

Locations: 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada
🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment

Phase 4

Completed

Conditions: Thyroid Cancer
Thyroid Goiter
Graves Disease

Interventions: Drug: Indocyanine Green

First Posted Date: 2019-05-31

Last Posted Date: 2020-03-27

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 10

Registration Number: NCT03969108

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Tongue Pressure Resistance Training for Swallowing Impairment Post-Stroke

Not Applicable

Terminated

Conditions: Stroke
Dysphagia

Interventions: Behavioral: Tongue Pressure Resistance Training

First Posted Date: 2019-05-31

Last Posted Date: 2022-06-21

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 1

Registration Number: NCT03969095

Locations: 🇨🇦
Toronto Rehabilitation Institute - University Health Network, Toronto, Ontario, Canada
🇺🇸
Marianjoy Hospital, Wheaton, Illinois, United States

Nasal High Flow Therapy in Surgical Patients with Unrecognized Obstructive Sleep Apnea

Not Applicable

Completed

Conditions: Obstructive Sleep Apnea
Sleep Disordered Breathing

Interventions: Other: Usual Care
Other: Nasal High Flow

First Posted Date: 2019-05-28

Last Posted Date: 2025-01-13

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 22

Registration Number: NCT03964376

Locations: 🇲🇾
Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
🇲🇾
University Malaya Medical Centre, Kuala Lumpur, Malaysia
🇸🇬
Singapore General Hospital, Singapore, Singapore

and more 5 locations

Surgical Patient Knowledge and Safe Use of Opioids

Not Applicable

Completed

Conditions: Opioid Use

Interventions: Other: Educational

First Posted Date: 2019-05-22

Last Posted Date: 2021-10-28

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100

Registration Number: NCT03959787

Locations: 🇨🇦
Women's College Hospital, Toronto, Ontario, Canada
🇨🇦
Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada

A Study to Desensitize Allergic Reactions to Treatments for Blood Disorders

Phase 2

Completed

Conditions: Amyloidosis
Multiple Myeloma

Interventions: Drug: Pomalidomide
Drug: Lenalidomide

First Posted Date: 2019-05-22

Last Posted Date: 2023-07-24

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 10

Registration Number: NCT03959358

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

IPACK Study in Total Knee Arthroplasty Patients

Phase 4

Completed

Conditions: Knee Replacement Arthroplasty

Interventions: Drug: Standard of Care (ACB, SA, peri-op pain management)
Drug: IPACK and multi-modal analgesic regimen
Procedure: Periarticular Local Anesthetic Infiltration
Drug: IV Dexamethasone 8mg at the end of surgery as standard of care

First Posted Date: 2019-05-17

Last Posted Date: 2022-04-29

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 78

Registration Number: NCT03954379

Locations: 🇨🇦
Toronto Western Hopspital, Toronto, Ontario, Canada

HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL

Phase 2

Not yet recruiting

Conditions: Anal Intraepithelial Neoplasia
Human Papilloma Virus
Anal Cancer

Interventions: Drug: 9-valent HPV vaccination

First Posted Date: 2019-05-13

Last Posted Date: 2022-06-13

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 228

Registration Number: NCT03947775

Locations: 🇨🇦
University of British Columbia, Vancouver, British Columbia, Canada
🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
🇨🇦
University Health Network - Toronto General Hospital, Toronto, Ontario, Canada

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy